Sugi Predict

Sugi Predict / Compounds / SCHEMBL20564874

SCHEMBL20564874

SCHEMBL20564874

NC(=O)c1c(-c2ccc(Cl)cc2Cl)nn2c(=O)c3ccc(Cl)cc3[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA9 Q16790 2/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CNR1 P21554 3/20 0.39
▸ CNR2 P34972 3/20 0.39
▸ HAVCR2 Q8TDQ0 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ LIN28A Q9H9Z2 1/20 0.38
▸ CDC7 O00311 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ DBF4 Q9UBU7 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ MAT2A P31153 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20565649 0.91 KDM4E (0.45) CNR1CNR2BTKLMNAKDM4E
SCHEMBL20565580 0.84 MAP2 (0.44) CNR1HAVCR2BTKKDM4ECYP2C9
SCHEMBL20565517 0.81 KDM4E (0.46) CNR1LMNAKDM4EMEN1MAPK1
SCHEMBL20565534 0.81 BTK (0.50) CNR1BTKCDK2LMNAKDM4E
SCHEMBL20565514 0.79 CNR1 (0.46) CNR1BTKLMNA
SCHEMBL20565509 0.78 HPGD (0.45) CA9CA12CNR1CNR2HAVCR2
SCHEMBL20564458 0.78 NR4A2 (0.46) CNR1LMNAKDM4EMEN1HPGD
SCHEMBL22000472 0.76 CA9 (0.39) CA9CA12HAVCR2LMNAMAT2A
SCHEMBL20565512 0.72 KDM4E (0.51) CNR1CDK2LMNAKDM4EMEN1
SCHEMBL20565125 0.71 CA9 (0.46) CA9CA12HAVCR2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192893-B2 Pyrazoloquinazolinone antitumor agents THE ROCKEFELLER UNIVERSITY (US) 2021-12-07 — — US disclosed
US-11192893-B2 Pyrazoloquinazolinone antitumor agents THE ROCKEFELLER UNIVERSITY (US) 2021-12-07 — — US disclosed
US-20200148687-A1 PYRAZOLOQUINAZOLINONE ANTITUMOR AGENTS THE ROCKEFELLER UNIVERSITY (US) 2020-05-14 — — US disclosed
US-20200148687-A1 PYRAZOLOQUINAZOLINONE ANTITUMOR AGENTS THE ROCKEFELLER UNIVERSITY (US) 2020-05-14 — — US disclosed
EP-3624805-A1 PYRAZOLOQUINAZOLINONE ANTITUMOR AGENTS Kapoor, Tarun, M. (US) 2020-03-25 — — EP disclosed
WO-2018213712-A1 PYRAZOLOQUINAZOLINONE ANTITUMOR AGENTS KAPOOR TARUN M (US) 2018-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200148687-A1 PYRAZOLOQUINAZOLINONE ANTITUMOR AGENTS H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, TPD52L2 CA9 1024/4885CA12 2784/4885CNR1 624/4885
US-11192893-B2 Pyrazoloquinazolinone antitumor agents H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, TPD52L2 CA9 1024/4885CA12 2784/4885CNR1 624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.